-
2022-502393-16-00
5
2023-09-06
Moderately to Severely Active Ulcerative Colitis
-
2022-502828-42-00
4
2023-09-01
Idiopathic Pulmonary Fibrosis
-
2022-502921-16-00
6
2023-07-21
Hemophilia A and B
-
2022-500535-36-01
5
2023-06-12
Moderately to severely active ulcerative colitis
-
2022-500905-42-00
3
2023-03-24
pancreatic ductal adenocarcinoma
-
2024-514761-19-00
5
2023-01-25
Idiopathic Pulmonary Fibrosis
-
2023-503793-20-00
5
2023-01-18
Prevention of ischemic stroke in patients post acute non-cardioembolic
-
2022-502078-17-00
4
2022-12-15
unresectable hepatocellular carcinoma
-
2024-510649-33-00
9
2022-09-02
Advanced/metastatic hepatocellular carcinoma (HCC)
-
2024-513559-34-00
5
2022-07-19
Small Cell Lung Cancer (SCLC)
-
2022-502392-37-00
4
2022-05-25
elderly patients (> = 60 years) with Acute Myeloid Leukemia
-
2023-505457-40-00
5
2022-02-02
Previously Untreated Advanced Gastric or Gastroesophageal Junction
Can
-
2023-506918-45-00
5
2021-05-17
Mild cognitive impairment (MCI) or mild dementia, both of the Alzheime
-
2023-506919-18-00
5
2021-05-17
Mild cognitive impairment (MCI) or mild dementia, both of the Alzheime
-
2024-512012-21-00
5
2021-04-08
Chronic Obstructive Pulmonary Disease
-
2023-504036-17-00
5
2020-05-07
Chronic Lymphocytic Leukemia (CLL)
-
2024-513984-22-00
4
2020-03-17
Patients with metastatic GIST
-
2023-507669-24-00
5
2019-11-05
Chronic lymphocytic leukemia
-
2024-515356-21-00
5
2018-04-17
Adult subject (18 years of age older) with low or intermediate-1 IPSS
-
2024-516783-29-00
6
2018-04-16
Severe allergic and eosinophilic asthma
-
2024-516098-62-00
5
2018-01-11
External Genital Warts (EGW)
-
2023-509595-42-00
5
2017-10-31
Gastric and gastroesophageal junction (GEJ) adenocarcinoma
-
2023-509227-41-00
4
Low risk of disease recurrence, defined by the following criteria:
- A
-
2024-519258-35-00
4
stomach cancer